Methods and compositions for treating virus-associated inflammation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 12, 2023
Grant Date -
N/A
app pub date -
Nov 12, 2021
filing date -
Dec 29, 2016
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The compositions and methods described herein include methods and agents that inhibit inflammasome signaling in a mammal such as antibodies directed against inflammasome components used alone or in combination with extracellular vesicle uptake inhibitor(s) or other agents. Also described herein are compositions and methods of use thereof for treating viral-associated lung inflammation, for example lung inflammation associated with viral infections such as SARS-CoV-2.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully